Compare AIZ & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIZ | GKOS |
|---|---|---|
| Founded | 1892 | 1998 |
| Country | United States | United States |
| Employees | N/A | 1094 |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 14.0B |
| IPO Year | 2003 | 2015 |
| Metric | AIZ | GKOS |
|---|---|---|
| Price | $317.55 | $238.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $355.17 | $243.85 |
| AVG Volume (30 Days) | 355.5K | ★ 1.5M |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | ★ 17.08 | N/A |
| EPS | ★ 16.82 | N/A |
| Revenue | ★ $12,814,300,000.00 | $507,442,000.00 |
| Revenue This Year | $9.62 | $53.82 |
| Revenue Next Year | $7.35 | $28.56 |
| P/E Ratio | $18.79 | ★ N/A |
| Revenue Growth | 7.89 | ★ 32.33 |
| 52 Week Low | $209.86 | $93.96 |
| 52 Week High | $326.99 | $255.19 |
| Indicator | AIZ | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 66.12 | 60.24 |
| Support Level | $273.54 | $147.72 |
| Resistance Level | N/A | $255.19 |
| Average True Range (ATR) | 6.66 | 11.87 |
| MACD | -0.36 | -1.86 |
| Stochastic Oscillator | 69.31 | 48.42 |
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions, consumer electronics and appliances services, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. In addition, the Company reports the Corporate and Other segment, which includes corporate employee-related expenses, activities of the holding company and investments in the home warranty business.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.